Vor Biopharma Inc. (VOR) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $941.0K | +310.9% |
| 2024 | $229.0K | -78.6% |
| 2023 | $1.07M | -87.4% |
| 2022 | $8.46M | +117.3% |
| 2021 | $3.89M | -6.4% |
| 2020 | $4.16M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $941.0K | +310.9% |
| 2024 | $229.0K | -78.6% |
| 2023 | $1.07M | -87.4% |
| 2022 | $8.46M | +117.3% |
| 2021 | $3.89M | -6.4% |
| 2020 | $4.16M | — |